Clik here to view.
AnHeart Therapeutics and Innovent Announce China’s NMPA Has Granted...
NEW YORK & SUZHOU, China AnHeart Therapeutics (“AnHeart”), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, and Innovent Biologics,...
View ArticleClik here to view.
Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop...
BEIJING & BARCELONA, Spain Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery and development of novel antibody...
View ArticleClik here to view.
Clik here to view.
Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine...
BEIJING & SAN DIEGO Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an antibody evaluation and option agreement with...
View ArticleClik here to view.
BeiGene to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in...
View ArticleClik here to view.
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to...
SAN DIEGO & SINGAPORE ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, announced a partnership with the Experimental Drug Development...
View ArticleClik here to view.
FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the U.S. Food and Drug Administration...
View ArticleClik here to view.
Shiseido to Acquire Dr. Dennis Gross Skincare
TOKYO Shiseido Company, Limited (The Prime Market of the Tokyo Stock Exchange: 4911) (“Shiseido”, “Company”) today announced that Shiseido Americas Corporation (“Shiseido Americas”), a subsidiary of...
View ArticleClik here to view.
Syncell Expands Into the United States With a New Office in Watertown, MA
TAIPEI, Taiwan & WATERTOWN, Massachusetts Syncell, a life science technology company known for pioneering next-generation spatial proteomics, is pleased to announce the inauguration of its US...
View ArticleClik here to view.
LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC
DAEJEON, South Korea LegoChem Biosciences, Inc. (KOSDAQ: 141080) announced on December 22 that it has entered into a license agreement with Janssen Biotech, Inc. (Janssen), a Johnson & Johnson...
View ArticleClik here to view.
CORRECTING and REPLACING LegoChem Biosciences Announces License Agreement for...
DAEJEON, South Korea The contact person’s name should read: Daeyoung Jeong. The updated release reads: LEGOCHEM BIOSCIENCES ANNOUNCES LICENSE AGREEMENT FOR LCB84 TROP2-TARGETED ADC LegoChem...
View ArticleClik here to view.
CCM Biosciences宣布成立5Prime Sciences业务部
新泽西州芒特劳雷尔 (美国商业资讯)– 多元化生物技术公司CCM Biosciences (CCM Bio)宣布成立业务部门CCM 5Prime Sciences (5Prime)，专注于开发和应用DNA生物技术领域的专有技术。5Prime的技术平台包括多个受专利保护且已实现全球商业化的组合物和方法，用于分子克隆、下一代DNA测序和分子诊断。...
View ArticleClik here to view.
CCMバイオサイエンシズ、「5プライム・サイエンシズ」事業部の立ち上げを発表
マウント・ローレル、ニュー・ジャージー州 （ビジネスワイヤ） — バイオテクノロジー分野の多角経営企業であるCCMバイオサイエンシズ（CCMバイオ）は、DNAバイオテクノロジーの領域における独自テクノロジーの開発と応用に焦点を当てた事業部、CCM...
View ArticleClik here to view.
InnoCare to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428) announced today that Dr. Jasmine Cui, Co-founder, Chairwoman and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference, at 08:30...
View ArticleClik here to view.
科望医药与安斯泰来就BiME®平台及候选药物达成合作开发及授权许可协议
苏州、上海、东京 (美国商业资讯)– 科望医药（董事会主席及首席执行官：纪晓辉博士，“科望”）与安斯泰来制药集团（TSE: 4503, 总裁及首席执行官：Naoki Okamura, “安斯泰来”) 于今日宣布就全新的BiME®...
View ArticleClik here to view.
Elpiscience and Astellas Enter into Research Collaboration and License...
Shanghai and Suzhou, TOKYO Elpiscience Biopharma, Ltd. (Chairman and CEO: Darren Ji, MD, Ph.D., “Elpiscience”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”)...
View ArticleClik here to view.
Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for...
JIANGSU, China Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic...
View ArticleClik here to view.
CDISC Names Chris Decker President and CEO
AUSTIN, Texas CDISC announces industry veteran Chris Decker is joining the organization as its new President and Chief Executive Officer effective January 2, 2024, succeeding Dave Evans who will be...
View ArticleClik here to view.
Avistone Biotechnology Announces Closing of Series B Financing
BEIJING Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced...
View ArticleClik here to view.
Delta-Fly Pharma Inc.: Update on the R＆D status of DFP-10917 and DFP-14927, a...
TOKUSHIMA, Japan Following the previous information on June 30th in 2023, we are excited to share our latest development status. A Phase III study of DFP-10917 in patients with recurrent or...
View Article